Inventor
Ekaterina Vladimirovna BREOUS-NYSTROM
Inventor
CH
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes13%
C12YEnzymes13%
PatentTitleYear
12,391,741T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof202512,011,481Anti-TIM-3 antibodies and methods of use thereof202411,839,653Anti-TIM-3 antibodies and methods of use thereof202311,718,658T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2024Patents assigned to AGENUS INC (2)· patent assignee history
2023–2025Patents assigned to MINK THERAPEUTICS INC (2)· patent assignee history
2023–2025Based in CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AGENUS INC | 2 | 2023–2024 |
| MINK THERAPEUTICS INC | 2 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 4 | 2023–2025 |